HIMS logo

HIMS

Hims & Hers Health Inc. Class A

$26.44
-$0.65(-2.40%)
49
Overall
20
Value
50
Tech
78
Quality
Market Cap
$9.60B
Volume
13.57M
52W Range
$23.97 - $72.98
Target Price
$42.77

Company Overview

Mkt Cap$9.60BPrice$26.44
Volume13.57MChange-2.40%
P/E Ratio76.2Open$27.11
Revenue$1.5BPrev Close$27.09
Net Income$126.0M52W Range$23.97 - $72.98
Div YieldN/ATarget$42.77
Overall49Value20
Quality78Technical50

No chart data available

About Hims & Hers Health Inc. Class A

Hims & Hers Health, Inc. operates a telehealth platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, and internationally. The company offers a range of curated prescription and non-prescription health and wellness products and services available to purchase on its websites and mobile application directly by customers. It also provides prescription medication on a recurring basis and ongoing care from healthcare providers; and over-the-counter drug and device products, cosmetics, and supplement products primarily focusing on general wellness, sexual health and wellness, skincare, and hair care. In addition, the company's curated non-prescription products include melatonin and biotin in the wellness specialty category; moisturizers, creams, sunscreen, serum, face oil, and face wash in the skincare specialty; condoms, climax delay spray and wipes, vibrators, and lubricants in the sexual health and wellness specialty; and shampoos, conditioners, scalp scrubs, and topical treatments, such as minoxidil in the hair care specialty category. Further, it offers medical consultation and post-consultation support services, as well as health and wellness products through wholesale partners. Hims & Hers Health, Inc. is based in San Francisco, California.

Sector: Health Care and Social Assistance
Industry: Offices of Physicians, Mental Health Specialists

Latest News

Analysts Are Bullish on These Healthcare Stocks: Hims & Hers Health (HIMS), Pharming Group (PHAR)

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Hims & Hers Health (HIMS – Research Report), Pharmin...

Howard Kim21 hours ago

Bank of America Securities Remains a Sell on Hims & Hers Health (HIMS)

TipRanks Auto-Generated Intelligence Newsdesk15 days ago

UAA, MARA, HIMS: The 10 Most Shorted Stocks in the Market

Joel Baglole17 days ago

Morning News Wrap-Up: Thursday’s Biggest Stock Market Stories!

William Whitea month ago

HIMS Stock Falls after BofA Slashes Price Target to a Street-Low of $29

Sheryl Shetha month ago
ABCD
1SymbolPriceChangeVol
2HIMS$26.44-2.4%13.57M
3
4
5
6

Get Hims & Hers Health Inc. Class A Data in Excel

Stream real-time data directly to your spreadsheets

BUY NOW
Stock data provided by MarketXLS.